2-Deoxy-2,2-difluoro-3,5-O-dibenzoylribose mesylate

CAS: 122111-11-9

Ref. 3D-XEA11111

Informação sobre produto

• Nome: 2-Deoxy-2,2-difluoro-3,5-O-dibenzoylribose mesylate
• Sinónimos: T8, D-erythro-pentofuranose, 2-deoxy-2,2-difluoro-, 3,5-dibenzoate 1-methanesulfonate, 2-Dexy-2,2-Difluoro-3,5-O-Dibenzoylribose Mesylate, 2-Deoxy-2,2-Difluoro-D-Erythro-Ribofuranose-3,5-Dibenzoate 1-Methanesulfonate, 2-Deoxy-2,2-Difluoro-D-Ribofuranose-3,5-Dibenzoate-1-Methanesulfonate, 2-Deoxy-2,2-difluoro-3,5-dibenzoyl-D-ribofuranose-1-methanesulfonate, 2-deoxy-2,2-difluoro-D-erythro-pentofuranos-1-ulose-3,5-dibenzoate-1-methanesulfonate, 4-amino-1-[(2S,4S,5S)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one, 2-Deoxy-2,2-difluoro-D-erythro-pentofuranose-3,5-dibenzoate-1-methanesulfonate(racemate), 2-Deoxy-2,2-Difluoro-D-Erythro-Pentofuranose-3,5-Dibenzoate-1-Methanesulfonate(T8), T8:2-deoxy-2,2-difluoro-D-ribofuranose-3,5-dibenzoate-1-methanesulfonate, 2-Deoxy-2,2,-difluoro-D-erythro-pentofuranose-3,5-dibenzoate-1-methanesulfonate

Descrição

Gemcitabine is an anticancer drug that belongs to the class of nucleoside analogs. It is a cytotoxic agent that inhibits the production of DNA and RNA in cells, thereby preventing their division. Gemcitabine has been used to treat various cancers, including pancreatic cancer, non-small cell lung cancer, prostate cancer, breast cancer and colon cancer. This drug has been shown to be effective against these cancers because it selectively targets rapidly dividing cells. The hydrochloric acid in gemcitabine is responsible for its solubility in water at low pH levels. Gemcitabine has two isomers: D-2-deoxy-2,2-difluoro-3,5-O-dibenzoylribose mesylate (DDFR) and L-2-deoxy-2,2-difluoro-3,5--O--dibenzoylribose mesylate (

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 456.42 g/mol
• Fórmula: C₂₀H₁₈F₂O₈S
• Pureza: Min. 95%